102 related articles for article (PubMed ID: 27461640)
1. Systemic lupus erythematous increased lung cancer risk: Evidence from a meta-analysis.
Wu Y; Hou Q
J Cancer Res Ther; 2016; 12(2):721-4. PubMed ID: 27461640
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematous and malignancy risk: a meta-analysis.
Cao L; Tong H; Xu G; Liu P; Meng H; Wang J; Zhao X; Tang Y; Jin J
PLoS One; 2015; 10(4):e0122964. PubMed ID: 25885411
[TBL] [Abstract][Full Text] [Related]
3. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
[TBL] [Abstract][Full Text] [Related]
4. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
5. The association of IL1α and IL1β polymorphisms with susceptibility to systemic lupus erythematosus: a meta-analysis.
Wang B; Zhu JM; Fan YG; Feng CC; Chen GM; Chen H; Pan HF; Ye DQ
Gene; 2013 Sep; 527(1):95-101. PubMed ID: 23747396
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk of metabolic syndrome in patients with systemic lupus erythematosus: A meta-analysis.
Sun C; Qin W; Zhang YH; Wu Y; Li Q; Liu M; He CD
Int J Rheum Dis; 2017 Aug; 20(8):917-928. PubMed ID: 28851080
[TBL] [Abstract][Full Text] [Related]
7. Risk of pancreatic cancer in patients with systemic lupus erythematosus: a meta-analysis.
Seo MS; Yeo J; Hwang IC; Shim JY
Clin Rheumatol; 2019 Nov; 38(11):3109-3116. PubMed ID: 31270697
[TBL] [Abstract][Full Text] [Related]
8. Smoking and the risk of systemic lupus erythematosus: an updated systematic review and cumulative meta-analysis.
Jiang F; Li S; Jia C
Clin Rheumatol; 2015 Nov; 34(11):1885-92. PubMed ID: 26188616
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of cervical HPV infection in women with systemic lupus erythematosus: A systematic review and meta-analysis.
García-Carrasco M; Mendoza-Pinto C; Rojas-Villarraga A; Molano-González N; Vallejo-Ruiz V; Munguía-Realpozo P; Colombo AL; Cervera R
Autoimmun Rev; 2019 Feb; 18(2):184-191. PubMed ID: 30572140
[TBL] [Abstract][Full Text] [Related]
10. Association between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to systemic lupus erythematosus: a meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
J Renin Angiotensin Aldosterone Syst; 2013 Sep; 14(3):248-54. PubMed ID: 23047029
[TBL] [Abstract][Full Text] [Related]
11. Risk of gestational diabetes mellitus in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis.
Dong Y; Dai Z; Wang Z; Wang H; Yuan F; Zhu Y; Ye D; Wang B
BMC Pregnancy Childbirth; 2019 May; 19(1):179. PubMed ID: 31113392
[TBL] [Abstract][Full Text] [Related]
12. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
[TBL] [Abstract][Full Text] [Related]
13. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
14. Role of the Fcgamma receptor IIIA-V/F158 polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis.
Li LH; Yuan H; Pan HF; Li WX; Li XP; Ye DQ
Scand J Rheumatol; 2010 Mar; 39(2):148-54. PubMed ID: 20059375
[TBL] [Abstract][Full Text] [Related]
15. Increased Pulse Wave Velocity in Systemic Lupus Erythematosus: A Meta-Analysis.
Wang P; Mao YM; Zhao CN; Liu LN; Li XM; Li XP; Pan HF
Angiology; 2018 Mar; 69(3):228-235. PubMed ID: 28635303
[TBL] [Abstract][Full Text] [Related]
16. Patients with asthma have a higher risk of systemic lupus erythematosus: a systematic review and meta-analysis.
Charoenngam N; Ponvilawan B; Wongtrakul W; Ungprasert P
Clin Rheumatol; 2021 Feb; 40(2):529-536. PubMed ID: 32638252
[TBL] [Abstract][Full Text] [Related]
17. Associations between interleukin 1 polymorphisms and susceptibility to systemic lupus erythematosus: a meta-analysis.
Song GG; Kim JH; Seo YH; Choi SJ; Ji JD; Lee YH
Hum Immunol; 2014 Jan; 75(1):105-12. PubMed ID: 24055697
[TBL] [Abstract][Full Text] [Related]
18. Association of MeCP2 (rs2075596, rs2239464) genetic polymorphisms with systemic lupus erythematosus: a meta-analysis.
Liu K; Zhang L; Chen J; Hu Z; Cai G; Hong Q
Lupus; 2013 Aug; 22(9):908-18. PubMed ID: 23857988
[TBL] [Abstract][Full Text] [Related]
19. Thrombocytopenia as a Prognostic Marker for Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
Chen Z; Zhong H; Dong G
Am J Med Sci; 2019 Jun; 357(6):461-467. PubMed ID: 30987767
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of systemic lupus erythematosus and the risk of cervical neoplasia.
Liu H; Ding Q; Yang K; Zhang T; Li G; Wu G
Rheumatology (Oxford); 2011 Feb; 50(2):343-8. PubMed ID: 20929972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]